Predictive Immune Biomarkers for COVID-19 Pathogenesis

NACompletedINTERVENTIONAL
Enrollment

565

Participants

Timeline

Start Date

March 4, 2020

Primary Completion Date

December 31, 2020

Study Completion Date

December 24, 2021

Conditions
COVID-19
Interventions
BIOLOGICAL

Blood collection on admission and longitudinally

33 mL of blood collected on admission (day 0) and longitudinally (day 4, 8 12 and in discharge)

BIOLOGICAL

Blood collection on their first consultation and 10 to 14 days later

33 mL of blood collected on their first consultation and 10 to 14 days later

Trial Locations (1)

31059

Purpan University Hospital, Toulouse

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER

NCT04385108 - Predictive Immune Biomarkers for COVID-19 Pathogenesis | Biotech Hunter | Biotech Hunter